Massachusetts FDA-Approved Adjunctive Ketamine Therapy For Depression Announced
Aug 27, 2023
Thrive IV (+1-508-848-8089), the Dartmouth-based ketamine and vitamin infusion center, announces a new expansion throughout Massachusetts.
Dartmouth, United States - August 27, 2023 /PressCable/ —
Thrive IV is now offering its ketamine infusion treatments to patients at a larger scale, providing access to a solution that - when overseen by a medical professional - has been linked to alleviation of depression symptoms.
More information can be found at https://www.thriveiv.net/
Thrive IV uses carefully administered intravenous ketamine to target NMDA receptors in the brain. Research indicates that ketamine can quickly relieve depression when other treatments have failed - and significant improvement is often seen within 24 hours.
"Ketamine may be the missing puzzle piece you’ve been searching for to help make everything more clear with a path to healing your brain and feeling your best," explains a spokesperson.
Millions struggling with depression find limited results from conventional antidepressants. The clinic notes that the number of patients with TRD could be as high as 60%, based on their studies and research. This has led to a rise in patients seeking alternative solutions.
Discovered in 1962, ketamine has since been used in a range of surgical and emergency procedures across the world. It was approved by the FDA for treatment-resistant depression via nasal spray in 2019.
Though not a cure, ketamine infusion therapy has demonstrated effectiveness for managing and reducing depression symptoms in clinical trials. These studies reveal short and long-term improvements. According to the Thrive IV team, ketamine infusions have helped approximately 80% of cases with treatment-resistant depression. While more research is still needed, these promising results suggest the treatment could offer much-needed relief.
It has also been effective in treating anxiety disorders and PTSD, Thrive IV notes. With 6.8 million US adults suffering from generalized anxiety disorder and only 43% getting treatment according to the clinic, ketamine represents a safe alternative to consider - and it is well-positioned to help patients regain mental well-being.
The spokesperson adds: "We specialize in adding ketamine infusions to help increase your feeling of well-being and reduce the terrible pain, depression, or anxiety you've been experiencing. Giving you hope to live a happier and more productive, fulfilled life."
Interested parties can learn more at https://www.thriveiv.net/
Contact Info:
Name: Dr. Michael Pellegrino
Email: Send Email
Organization: Thrive IV
Address: 49 State Rd Nauset Building #102, Dartmouth, MA 02747, United States
Phone: +1-508-848-8089
Website: http://www.ThriveIV.net
Source: PressCable
Release ID: 89105949
In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting [email protected]. Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.
More News
Japan enlists royal visit, subsidies to revive tourism in quake-hit Kyushu
Travel companies in southern Japan are pinning their hopes on a business revival following a planned visit by Emperor Naruhito and Empress Masako to the areas hardest hit by a major earthquake this summer. The imperial couple, who were scheduled to meet communities in Kumamoto prefecture on Tuesday, postponed the trip due to poor weather. On Wednesday, they will speak with families currently living in temporary accommodation after losing their homes and businesses. The prefecture was at the...
Hong Kong mustn’t miss the boat on the Pinglu Canal and Asean trade
The official opening of the Pinglu Canal on September 16 is a milestone in modern Chinese history. More than an infrastructural feat, it signals a strategic recalibration of how China’s inland economies connect with the sea and Southeast Asia, and augurs the next phase of regional growth. Designed for vessels of up to 5,000 tonnes, the 134.2km (83.4 mile) waterway stretches from the Xijin reservoir in Hengzhou, an emerging city in Guangxi, to the Gulf of Tonkin (known as the Beibu Gulf in...
Australian firm drops US$842 million Sydney data centre plan after public fury
Australian industrial property developer Goodman Group has withdrawn an application to develop a 24-hour data centre on Sydney’s north shore following public push back. Goodman said it would not proceed with its Project Mars development application after considering evolving federal and state policy and community feedback. Policy and regulation around large artificial intelligence data centres had “evolved significantly” since planning began in March 2025, the company said in a statement. The...
In Japan, anti-foreigner fake news drives far-right gains
Japan risks being pulled into a spiral of online disinformation about foreign crime that is stoking xenophobia and playing into the hands of the far-right, researchers warn. The trend is reportedly deepening divisions within Japanese society and creating a feedback loop that experts say will be difficult to break. In August, Constella Security Japan, a Tokyo-based cybersecurity firm commissioned by the government to counter online disinformation, hosted a webinar for officials and media on fake...
In the US-China AI race, the real fight is keeping humans in control
The US-China AI competition faces a dilemma. Both countries see artificial intelligence as a source of economic, scientific and strategic power, so neither has much incentive to slow down. Yet the more capable and autonomous AI becomes, the more important the question of human control. Last week’s summit between US President Donald Trump and Chinese President Xi Jinping brought that tension into the open. Trump wants to leave AI “exactly where it is” rather than add new guardrails, while Xi...
Trump Offered to Sell Arms to China, U.S. Ambassador Says
President Trump made the offer to Xi Jinping, China’s leader, said David Perdue, the ambassador to China. The White House later said the U.S. had no plans for such a sale.
Two of China’s EV Makers Announce a Deal as Auto Industry Moves Toward Consolidation
Two of the country’s leading makers of electric vehicles announced they are merging their battery swapping and charging operations.
Is AUKUS Too Big to Fail?
The AUKUS partnership survived the Trump transition, and for Canberra it may be too big a deal to ever let fail.
What South Korea Means by Protecting ‘Diverse Families’
A record family ministry budget proposal expands support beyond the traditional household, but a bill to recognize unmarried civil partnerships remains under review.
India’s Sheikh Hasina Dilemma
New Delhi’s difficult decision serves as a masterclass in how personal diplomacy can trap a major power.
Options for the Royal Brunei Air Force’s Fast-jet Decision
One important mantra for the RBAirF: Don’t try to run before you can walk.
Europe’s Read of the Trump-Xi Summit
Decisions taken in Washington and Beijing increasingly shape European trade, technology, energy, and security.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.